Puerperal Disorders: Clinical Trials

75 trials for Puerperal Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

45 completed, 11 unknown, 7 terminated, 4 not yet recruiting. 75 Phase 2, 14 Phase 3, 13 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 275Completed 45, Unknown 11, Terminated 7, Not yet recruiting 4, Recruiting 3, Withdrawn 3, Active not recruiting 2
Phase 314Completed 8, Active not recruiting 2, Unknown 2, Terminated 1, Withdrawn 1
Phase 113Completed 5, Unknown 3, Not yet recruiting 2, Recruiting 1, Terminated 1, Withdrawn 1

Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders

Trials (filtered) newest first · largest first

All 75 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis
Tocilizumab - Granulomatous Lobular Mastitis, Granulomatous Mastitis
Phase 1 / Phase 2Not yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University312026-06-012026-05-19
Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage
Oxytocin sublingual, Oxytocin IM - Post Partum Hemorrhage
Phase 2Not yet recruitingInsud Pharma3302026-05-302026-04-23
Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section
Calcium Chloride, Placebo - Post Partum Haemorrhage, Cesarean Section Surgery
Phase 2Not yet recruitingPak Emirates Military Hospital1822026-05-012026-04-24
Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis
Steroid, Antibiotic - Granulomatous Mastitis
Phase 1 / Phase 2Not yet recruitingAll India Institute of Medical Sciences, Bhubaneswar722026-03-152026-03-06
The Perinatal Synergistic Multi-component Intervention to alLeviate dEpressive Symptoms. A Case Series
interpersonal psychotherapy (IPT), Ketamine - Postpartum Depression
Phase 2 / Phase 3WithdrawnWashington University School of Medicine2025-10-152025-10-29
Oxytocin Pharmacokinetics and Pharmacodynamics
deuterated oxytocin (d5OT) - Post Partum Hemorrhage, Cesarean Section Complications
Phase 2RecruitingStanford University1002025-01-012026-08-21
High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth
Oxytocin - Postpartum Hemorrhage, Pregnancy Complications
Phase 2WithdrawnUniversity of Chicago2024-10-012024-12-10
Efficacy of MI078 Capsules in Treating Postpartum Depression
MI078 capsule dose 1, MI078 capsule dose 2, placebo - Postpartum Depression
Phase 2CompletedNanjing Minova Pharmaceutical Co., Ltd.722024-09-092026-06-25
RE104 Safety and Efficacy Study in Postpartum Depression
RE104 for Injection - Postpartum Depression
Phase 2CompletedReunion Neuroscience Inc842024-06-142026-05-14
A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression
NORA520 Dose 1, NORA520 Dose 2, Placebo - Depression, Postpartum, Postpartum Depression
Phase 2CompletedTWi Biotechnology, Inc.932024-03-282026-07-31
A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)
BRII-296, Depo Medrol - Severe Postpartum Depression
Phase 2CompletedBrii Biosciences Limited112023-09-292025-01-27
A Phase II Study of HS-10353 in Participants With Postpartum Depression
HS-10353 Capsules 30 mg, Oral, QN for 14 days, HS-10353 Capsules 50 mg, Oral, QN for 14 days, HS-10353 Capsules matching placebo, 30mg, Oral, QN for 14 days. - Postpartum Depression
Phase 2UnknownJiangsu Hansoh Pharmaceutical Co., Ltd.962023-08-312023-07-10
Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women
Carbetocin 100 Microgram/mL Solution for Injection - Obesity, Maternal, Post Partum Hemorrhage
Phase 1 / Phase 2CompletedCairo University1502023-07-062024-01-22
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
MWSH plus Candlelit Care, MWSH - Pregnancy Related, Pregnancy Complications
Phase 2 / Phase 3Active not recruitingCedars-Sinai Medical Center1502023-06-012026-10-22
Phase 2 Clinical Trial of GH001 in Postpartum Depression
GH001 - Postpartum Depression, Postnatal Depression
Phase 2TerminatedGH Research Ireland Limited102023-03-022025-02-18
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Tranexamic acid, No intervention - Post Partum Hemorrhage
Phase 2RecruitingInova Health Care Services1202022-12-282026-10-16
The SUPPORT Study: Effectiveness and Usability of a Web-Enabled Resource for Postpartum Mental Health
Postpartumcare.ca (Web-Enabled Intervention) - Postpartum Depression, Postpartum Anxiety
Phase 2CompletedUniversity of British Columbia1032022-04-202023-05-10
Prevention of Primary Postpartum Haemorrhage
Misoprostol, Oxytocin - Primary, Post Partum Hemorrhage
Phase 2UnknownIslamabad Medical and Dental College1802021-02-032021-02-25
Maternal Mental Health Trial
Transdermal patch estradiol, Transdermal patch placebo - Major Depressive Disorder, Postpartum Depression
Phase 1 / Phase 2RecruitingVibe G Frøkjær, MD, PhD2202021-02-032021-09-23
A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)
fibrinogen concentrate, Placebo - Postpartum Hemorrhage
Phase 1 / Phase 2WithdrawnYale University2021-01-012021-03-15

Showing 20 of 75. Sign in to see all of them.

Narrower conditions

Postpartum Hemorrhage (34)  ·  Depression, Postpartum (33)  ·  Depression (11)  ·  Hemorrhage (5)  ·  Pregnancy Complications (4)  ·  Anxiety Disorders (3)  ·  Mental Disorders (3)  ·  Mood Disorders (3)  ·  Anemia (2)  ·  Behavioral Symptoms (2)  ·  Breast Feeding (2)  ·  Depressive Disorder (2)  ·  Granulomatous Mastitis (2)  ·  Mastitis (2)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (75)  ·  Urogenital Diseases (75)  ·  Pregnancy Complications (71)  ·  Pathological Conditions, Signs and Symptoms (38)  ·  Pathologic Processes (35)  ·  Obstetric Labor Complications (34)  ·  Uterine Hemorrhage (34)  ·  Depressive Disorder (31)  ·  Mental Disorders (30)  ·  Mood Disorders (30)  ·  Hemorrhage (29)  ·  Behavior (15)  ·  Behavioral Symptoms (10)  ·  Signs and Symptoms (6)

Interventions

Misoprostol (11)  ·  Oxytocin (11)  ·  Tranexamic Acid (8)  ·  Estradiol (3)  ·  Ketamine (3)  ·  Sodium Chloride (3)  ·  Fibrinogen (2)  ·  Injections (2)  ·  Interpersonal Psychotherapy (2)  ·  Leuprolide (2)  ·  Progesterone (2)  ·  Saline Solution (2)  ·  brexanolone (2)  ·  carbetocin (2)  ·  ganaxolone (2)

Sponsors

Ain Shams University (3)  ·  Cairo University (3)  ·  Ain Shams Maternity Hospital (2)  ·  Assiut University (2)  ·  Benha University (2)  ·  Marinus Pharmaceuticals (2)  ·  Massachusetts General Hospital (2)  ·  National Institute of Mental Health (NIMH) (2)  ·  Pakistan Institute of Living and Learning (2)  ·  Qazvin University Of Medical Sciences (2)  ·  Supernus Pharmaceuticals, Inc. (2)  ·  Universidad Complutense de Madrid (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Women and Infants Hospital of Rhode Island (2)  ·  Aga Khan University (1)

Countries

United States (26)  ·  Egypt (11)  ·  Pakistan (5)  ·  Iran (4)  ·  Canada (3)  ·  China (3)  ·  Denmark (2)  ·  Spain (2)  ·  Bangladesh (1)  ·  Brazil (1)  ·  Germany (1)  ·  India (1)  ·  Iraq (1)  ·  Netherlands (1)  ·  Nigeria (1)

Top investigators

Peter J Schmidt, M.D. (2)  ·  Stephen J Kanes, MD, PhD (2)  ·  Abubaker M Elnashar, MD (1)  ·  Alison M Stuebe, MD, MSc (1)  ·  Amgad E. Abou-Gamrah, Ass.Prof. (1)  ·  Aminur Rahman, MBBS,MSc (1)  ·  Amr Yehia, MD, MRCOG (1)  ·  Anna Palatnik, MD (1)  ·  Anne J. Wikkelsoe, MD (1)  ·  Arash Afshari, MD (1)  ·  Ariana Kh. Jawad, Assistant professor (1)  ·  Arunporn Itharat, PH.D. (1)  ·  Ashish Premkumar, MD, PhD (1)

Results publications

PMID 10467792, PMID 10908457, PMID 11502292, PMID 14600674, PMID 15954876, PMID 16390366, PMID 16581405, PMID 16842791, PMID 17197859, PMID 17634155, PMID 17650319, PMID 19432563, PMID 19943825, PMID 20009308, PMID 20187965, PMID 20455694, PMID 20884642, PMID 22540529, PMID 22805300, PMID 22882240, PMID 24880136, PMID 25586727, PMID 26454186, PMID 26611780, PMID 28480799, PMID 28619476, PMID 28707488, PMID 29025850, PMID 29316912, PMID 30447565, PMID 31598047, PMID 32609374, PMID 32987448, PMID 33064852, PMID 33078388, PMID 33181049, PMID 33248975, PMID 33705565, PMID 35038612, PMID 35141873, PMID 35763351, PMID 36934142, PMID 37491196, PMID 37626292, PMID 37883133, PMID 37990597, PMID 38709329, PMID 38767196, PMID 39732915, PMID 40113655

NIH funding

2008 (1), 2009 (1), K23HL141640 (1), K23MH066265 (1), KL2TR001877 (1), R01HD093901 (1), R01HD110109 (1), R01MH071766 (1), R01MH074636 (1), R01MH074919 (1), R21HD090396 (1), R21MD017396 (1), R21MH085176 (1), R21MH119615 (1), UL1TR001876 (1)